A Phase IIclinical Trial of Carboplatin and Paclitaxel or Carboplatin and Gemcitabine in Platinum-sensitive, Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

Clinical trial NCT01570582 · UNKNOWN

Trial details

NCT number: NCT01570582
Sponsor: Korean Gynecologic Oncology Group
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Fallopian Tube Cancer Ovarian Cancer Primary Peritoneal Cancer

Start date: 2010-03-01
Primary completion: 2014-03-01
Enrollment: 314

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.